Cardiovascular breakthrough: Nanoparticle therapy cuts plaque buildup in arteries

Researchers at Michigan State University developed a nanotherapy infusion to treat arterial plaque inflammation, a major cause of heart attacks. The therapy uses nanoparticles to target immune cells within plaque, activating them to break down the core and reduce inflammation. Successfully tested on pigs without harmful side effects, the treatment has been scaled up to liter production, advancing towards potential human use. This breakthrough could significantly impact cardiovascular disease treatment worldwide.